Internal Medicine · New York, NY
NPI
1316979651
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
141 Division St, Fl 2
New York, NY, 10002
Phone (212) 608-1070
Medicare paid, 2024
$39K
705 services
Medicare patients, 2024
68
Average age 83
Drug cost, 2024
$3.5M
19,534 prescriptions
Company payments, 2025
$1,841
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kuocheng Wang was code 99212 (office e&m - established), 367 times for 61 patients. In total Kuocheng Wang billed 705 services in 19 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99212 Office E&M - Established | Office | 367 | 61 | $42.86 | $16K |
| 99213 Office E&M - Established | Office | 85 | 43 | $64.10 | $5,448 |
| 99214 Office E&M - Established | Office | 73 | 40 | $95.64 | $6,982 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 57 | 32 | $33.45 | $1,907 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 24 | 24 | $143.99 | $3,456 |
| 36415 Venipuncture Blood Collection | Office | 22 | 17 | $8.65 | $190 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 21 | 21 | $21.15 | $444 |
| 90662 Vaccine Product | Office | 14 | 14 | $81.82 | $1,145 |
| G0008 Administration of influenza virus vaccine | Office | 12 | 12 | $29.40 | $353 |
By year: 2022 $70K for 1,171 services; 2023 $60K for 1,014 services; 2024 $39K for 705 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 22 | 17 | $8.65 | $190 |
Medicare prescription drug claims, 2024
In 2024, the drug Kuocheng Wang prescribed most often to Medicare patients was Amlodipine Besylate, with 1,312 prescriptions and refills. In total Kuocheng Wang wrote 19,534 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,312 | 1,803 | 168 | $4,801 |
| Atorvastatin Calcium Generic | 1,300 | 1,813 | 165 | $6,367 |
| Losartan Potassium Generic | 791 | 1,095 | 107 | $3,872 |
| Farxiga Dapagliflozin Propanediol | 689 | 936 | 94 | $525K |
| Diclofenac Epolamine Generic | 662 | 772 | 85 | $517K |
| Metformin Hcl Er Metformin Hcl | 633 | 838 | 76 | $3,322 |
| Quetiapine Fumarate Generic | 583 | 625 | 86 | $3,953 |
| Vascepa Icosapent Ethyl | 536 | 619 | 66 | $212K |
| Azelastine Hcl Generic | 529 | 593 | 92 | $9,830 |
| Metoprolol Succinate Generic | 481 | 607 | 73 | $3,612 |
| Omeprazole Generic | 457 | 527 | 80 | $3,475 |
| Jardiance Empagliflozin | 447 | 536 | 57 | $311K |
| Tamsulosin Hcl Generic | 417 | 535 | 59 | $2,194 |
| Finasteride Generic | 413 | 546 | 58 | $1,854 |
| Rosuvastatin Calcium Generic | 328 | 462 | 43 | $1,911 |
Brand drugs: 4,915 claims; generic drugs: 14,365 claims; opioid claims: 52.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kuocheng Wang $1,841 ($1,841 in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $361.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 17 | $361 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 13 | $218 |
| Gilead Sciences, Inc. GILD | 4 | $191 |
| Lundbeck LLC | 7 | $188 |
| Globus Medical, Inc. GMED | 1 | $166 |
| Amgen Inc. AMGN | 3 | $160 |
| Exact Sciences Corporation EXAS | 5 | $132 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $103 |
| GlaxoSmithKline, LLC. GSK | 5 | $90.31 |
| Pfizer Inc. PFE | 3 | $81.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.